# FDA Inspection 1018903 - Dottikon Exclusive Synthesis AG - July 14, 2017

Source: https://www.keypedia.com/records/fda_inspections/dottikon-exclusive-synthesis-ag/33ea55f9-9235-44ba-95c1-0ae5f9f98edd
Source feed: FDA_Inspections

> FDA Inspection 1018903 for Dottikon Exclusive Synthesis AG on July 14, 2017. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1018903
- Company Name: Dottikon Exclusive Synthesis AG
- Inspection Date: 2017-07-14
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1194879 - 2022-12-16](https://www.keypedia.com/records/fda_inspections/dottikon-exclusive-synthesis-ag/a7ab4b39-b43b-4cc9-9d54-235c69557e7f)
- [FDA Inspection 1194879 - 2022-12-16](https://www.keypedia.com/records/fda_inspections/dottikon-exclusive-synthesis-ag/59d830da-891d-4b49-848d-46af544e3fc0)
- [FDA Inspection 1018903 - 2017-07-14](https://www.keypedia.com/records/fda_inspections/dottikon-exclusive-synthesis-ag/60285739-0f29-496f-8273-c76ab6c0ed69)
- [FDA Inspection 944297 - 2015-09-11](https://www.keypedia.com/records/fda_inspections/dottikon-exclusive-synthesis-ag/a34ed3be-c9a4-4517-b38c-c79c0f3ced13)
- [FDA Inspection 944297 - 2015-09-11](https://www.keypedia.com/records/fda_inspections/dottikon-exclusive-synthesis-ag/d32c57c5-b9af-453b-b9bb-e879452a9283)

Company: https://www.keypedia.com/companies/dottikon-exclusive-synthesis-ag/db7bdf8b-bd88-416f-94f2-62f946e90074

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c